List of insiders holdings for MetaVia Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | DONG-A ST CO. LTD 10% Owner |
2024-09-20 16:20:16 | 11,709,117 0 |
11,709,117 | Form 4 |
| 2 | E&Investment Inc. E&Healthcare Investment Fund II 10% Owner |
2022-08-05 16:25:36 | 6,113,798 0 |
6,113,798 | Form 13D |
| 3 | E&Investment Inc. E&Healthcare Investment Fund II E&Healthcare Investment Fund No.7 10% Owner |
2022-08-05 16:25:36 | 6,113,798 0 |
6,113,798 | Form 13D |
| 4 | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner |
2022-11-22 16:46:00 | 0 1,220,502 |
1,220,502 | Form 3 |
| 5 | Bakshi Akash SVP and COO |
2021-01-05 16:09:02 | 29,013 884,072 |
913,085 | Form 4 |
| 6 | Sooch Mina President & CEO |
2017-02-14 16:37:38 | 813,383 0 |
813,383 | Form 13G |
| 7 | Lowenschuss David Chief Legal Off. & Secretary |
2017-02-14 14:10:25 | 806,247 0 |
806,247 | Form 13G |
| 8 | Price Ben Gil CEO and President |
2021-11-04 16:57:38 | 616,666 0 |
616,666 | Form 4 |
| 9 | Versavel Mark Chief Medical Officer |
2020-01-02 21:54:16 | 342,930 0 |
342,930 | Form 4 |
| 10 | Kim Na Yeon Director 10% Owner |
2023-07-28 06:08:20 | 101,459 200,554 |
302,013 | Form 4 |
| 11 | Oniciu Carmen Daniela Vice President |
2016-08-12 12:56:23 | 152,646 0 |
152,646 | Form 4 |
| 12 | SASSINE ANDY Director |
2019-07-26 16:38:02 | 151,264 0 |
151,264 | Form 4 |
| 13 | Golden Lee Scott Chief Medical Officer |
2018-01-30 16:27:49 | 148,000 0 |
148,000 | Form 4 |
| 14 | Reno Seth Chief Commercial Officer |
2019-07-26 16:16:56 | 118,286 0 |
118,286 | Form 4 |
| 15 | LICHTINGER PEDRO Director |
2019-07-26 16:30:59 | 74,833 0 |
74,833 | Form 4 |
| 16 | Kim Hyung Heon CEO & President |
2025-03-04 16:01:15 | 61,004 0 |
61,004 | Form 4 |
| 17 | Gullans Steven R. Ph.D. Director |
2020-01-15 19:11:20 | 60,000 0 |
60,000 | Form 4 |
| 18 | Jeong Tae Heum Director |
2020-01-15 19:12:48 | 60,000 0 |
60,000 | Form 4 |
| 19 | Oh Jeong Gyun Director 10% Owner |
2020-01-15 19:15:33 | 60,000 0 |
60,000 | Form 4 |
| 20 | Swirsky Douglas J Director |
2020-09-03 18:48:57 | 60,000 0 |
60,000 | Form 4 |
| 21 | Bisgaier Charles PhD Chief Scientific Off. & Chair 10% Owner |
2020-01-10 08:28:40 | 58,012 0 |
58,012 | Form 13D |
| 22 | MATHIESEN JEFFREY S Chief Financial Officer |
2018-01-30 16:20:41 | 48,000 0 |
48,000 | Form 4 |
| 23 | Woodworth Marshall H Chief Financial Officer |
2025-03-04 16:01:49 | 30,079 0 |
30,079 | Form 4 |
| 24 | KOUSKY KENNETH W Director |
2019-07-26 16:24:40 | 26,935 0 |
26,935 | Form 4 |
| 25 | Kang Richard Director |
2022-06-10 17:25:24 | 20,000 0 |
20,000 | Form 4 |
| 26 | STRICKLAND D GORDON Director |
2024-06-07 19:24:44 | 17,552 0 |
17,552 | Form 4 |
| 27 | KOVEN ANDREW I Director |
2024-06-07 19:25:32 | 17,552 0 |
17,552 | Form 4 |
| 28 | GROVES JASON L Director |
2024-06-07 19:26:08 | 17,552 0 |
17,552 | Form 4 |
| 29 | Salsbury Michael Director |
2024-06-07 19:26:37 | 17,552 0 |
17,552 | Form 4 |
| 30 | Hawryluk P. Kent Director |
2018-01-30 16:44:30 | 10,800 0 |
10,800 | Form 4 |
| 31 | Glickman Mark A Director |
2024-06-07 19:25:09 | 9,740 0 |
9,740 | Form 4 |
| 32 | Tursi James Patrick Director |
2024-06-07 19:24:16 | 9,072 0 |
9,072 | Form 4 |
| 33 | Hooker Joseph Interim CEO and President |
2023-01-18 16:15:44 | 0 0 |
0 | Form 3 |
| 34 | JK BioPharma Solutions Inc Kang Sun Dae 10% Owner |
2022-09-23 16:20:23 | 0 0 |
0 | Form 13D |
| 35 | Shannon Nicola VP, Clinical Operations |
2019-12-30 21:31:01 | 0 0 |
0 | Form 3 |